Canada markets closed

Anebulo Pharmaceuticals, Inc. (214.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
2.76000.0000 (0.00%)
At close: 03:29PM CEST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

Currency in USD. All numbers in thousands
Breakdown
ttm
2023-06-30
2022-06-30
2021-06-30
Cash flows from operating activities
Net Income
-9,347
-11,732
-6,826
-30,253
Stock based compensation
805.263
884.723
480.661
199.947
Change in working capital
-436.639
1,164
907.784
-1,445
Accounts Payable
-185.982
153.717
270.78
110.048
Other working capital
-8,887
-9,683
-5,437
-4,871
Net cash provided by operating activites
-8,887
-9,683
-5,437
-4,871
Cash flows from financing activities
Debt repayment
-
-
0
-201.286
Common stock issued
0
6,647
0
22,855
Common stock repurchased
-
-
-
0
Other financing activites
-130.51
-317.083
-
-821.63
Net cash used privided by (used for) financing activities
-130.51
6,382
0
21,832
Net change in cash
-9,018
-3,301
-5,437
16,961
Cash at beginning of period
14,165
14,548
19,986
3,025
Cash at end of period
5,147
11,247
14,548
19,986
Free Cash Flow
Operating Cash Flow
-8,887
-9,683
-5,437
-4,871
Free Cash Flow
-8,887
-9,683
-5,437
-4,871